Search clinical trials for: Bi-Manu-Track

Total 2724 results

National Taiwan University Hospital
Ministry of Science and Technology, Taiwan; National Health Research Institutes...

Recruiting

Proximal Priority Versus Distal Priority Robotic Priming Effects in Patients With Chronic Stroke

Stroke

Taiwan
Chang Gung Memorial Hospital

Withdrawn

Efficacy of Unilateral Versus Bilateral Approach to Robot-Assisted Rehabilitation in Patients With Subacute Stroke

Subacute Stroke

Taiwan
Chang Gung Memorial Hospital

Completed

Effects of Intensive Robot-assisted Therapy in Patients With Subacute Stroke (RT)

Stroke

Taiwan
Centers for Disease Control and Prevention
University of Rochester

Completed

Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM (3MV)

HIV Infections | Sexually Transmitted Diseases

United States
Henry Ford Health System
University of Michigan; Geisinger Clinic

Completed

Encouraging Young Adults to Make Effective Nutrition Choices (MENU GenY)

Improve Dietary Behaviors in Young Adults 21-30 Years of Age

United States
University of Jena

Completed

Nutritional Evaluation - NuEva Study (NuEva)

Nutritional Evaluation

Germany
San Diego State University

Completed

Kids' Choice Restaurant Program (KCRP)

Childhood Obesity

United States
North Carolina Central University
University of North Carolina, Chapel Hill

Completed

Improving the Diabetic Health of Black Men: MANUP Feasibility Trial (MANUP-NC)

Diabetes Mellitus, Type 2 | Coping Behavior | Self Efficacy | Masculinity

United States
University of Minnesota
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effect of Nutrition Labeling on Fast Food Choices

Healthy

United States
University of California, Davis

Completed

Menu Label Noticeability

Noticing Nutrition Information | Recalling Nutrition Information

United States
E-Star BioTech, LLC
Mayo Clinic; Integrium

Completed

Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects (DTC/RHS)

Resistant Hypertension | Difficult to Control Hypertension

United States
University of California, Davis
Center for Science in the Public Interest (CSPI)

Completed

Perceived Effectiveness of Added Sugar Labels

Health Knowledge | Attitude to Health

United States
University of Alabama at Birmingham
Texas Tech University

Completed

Effects of Restaurant Menu Design on Food Ordering Outcomes

Food Preferences
Carnegie Mellon University

Completed

Fast Food Photo Study 2

Obesity

United States
State University of New York - Downstate Medical...
National Institute of Mental Health (NIMH); Yale University

Enrolling by invitation

Leveraging Family-Based Assets for Black MSM In House Ball Communities

HIV I Infection

United States
University of Arizona
Jazz Pharmaceuticals

Completed

Community-Level Daytime Sleepiness: Social-Environmental Determinants, Consequences, and Impact of Sleep Apnea

Daytime Sleepiness

United States
University of Liverpool

Completed

Increasing Availability of Lower Energy Meals vs. Menu Energy Labelling on Food Choice

Obesity | Diet, Healthy | Food Selection | Nutrition Poor

United Kingdom
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood

Healthy

Germany
Boehringer Ingelheim

Recruiting

A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Melanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)

Netherlands
Boehringer Ingelheim

Completed

This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood

Healthy

Germany
Mayo Clinic

Withdrawn

MANP in African Americans With Hypertension (MANP-2)

Hypertension, Resistant to Conventional Therapy

United States
E-Star BioTech, LLC
Mayo Clinic; PPD

Not yet recruiting

To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension

Difficult to Control Hypertension
Boehringer Ingelheim

Withdrawn

A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer

Anal Canal Squamous Cell Carcinoma

Korea, Republic of
RAND

Recruiting

Testing Legally Feasible Options Studies 2/3

Tobacco Use

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Completed

Medical College Students' Responds to Menu Labeling

Dietary Modification
Yale University
National Institute of Nursing Research (NINR)

Completed

Promoting Reductions in Intersectional StigMa (PRISM) - GHANA

HIV | Stigma

Ghana
Boehringer Ingelheim

Active, not recruiting

A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body

Solid Tumors

Hungary
Boehringer Ingelheim

Terminated

A Study in Healthy Men to Find the Best Formulation of BI 894416 and to Test How This is Taken up in the Body

Healthy

United Kingdom
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body

Healthy

Netherlands
Boehringer Ingelheim

Not yet recruiting

A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity

Obesity
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects

Healthy | Asthma

Germany
University of Pennsylvania
National Institute on Aging (NIA)

Completed

Making Calories Count: Information Format and Food Choice

Obesity

United States
San Camillo Hospital, Rome
Fondazione Italiana Sclerosi Multipla; Fondazione Don Carlo Gnocchi Onlus; University... and other collaborators

Recruiting

Home-based EXergames To impRove cognitivE Function in MUltiple Sclerosis (EXTREMUS)

Multiple Sclerosis

Italy
Brigham and Women's Hospital
Duke University; Weill Medical College of Cornell University; Florida International... and other collaborators

Completed

Immediate Fast-Track Versus Standard Care for Persons Living With HIV in Haiti

HIV/AIDS

Haiti
Boehringer Ingelheim

Completed

A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet

Healthy

Netherlands
Boehringer Ingelheim

Completed

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Neoplasms | Carcinoma, Non-Small-Cell Lung

United States, Spain, United Kingdom, Canada, Poland
Boehringer Ingelheim

Terminated

A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread

Neoplasms | Carcinoma, Non-Small-Cell Lung | Neoplasm Metastasis

United States
University of Hawaii

Recruiting

Natives Engaged in Alzheimers Research - 'Ike Kupuna (NEAR)

Mild Cognitive Impairment | Subjective Cognitive Impairment

United States
Boehringer Ingelheim

Completed

Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.

Healthy

Germany
NYU Langone Health

Completed

Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.

Chronic Kidney Diseases | Hyperkalemia

United States
Taichung Veterans General Hospital

Completed

Subjects With Clinical Diagnosis of Allergic Rhinitis Were Randomly Divided Into 2 Groups, With Patients in One Group Given One Treatment Session of Red Light Rhinophototherapy, Followed by Medical Treatment. Those in the Second Group Were Treated With Medical Treatment Only.

Allergic Rhinitis | Phototherapy

Taiwan
Boehringer Ingelheim

Completed

A Study to Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])

Solid Tumors, KRAS Mutation

Japan
Boehringer Ingelheim

Completed

A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors)

Solid Tumors

Japan
Boehringer Ingelheim

Recruiting

A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood

Healthy

Germany
Boehringer Ingelheim

Recruiting

IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack (IRI-EXPLORE)

Myocardial Infarction

Korea, Republic of, Germany, Spain, Hungary, United Kingdom, Italy, Canada, Australia, Poland, Slovakia, New Zealand
Boehringer Ingelheim

Recruiting

A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer

Neuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)

Netherlands
Boehringer Ingelheim

Completed

A Study in Healthy Men and Women to Test if Taking Different Formulations of BI 730357 Tablets Influences the Amount of BI 730357 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food

Healthy

Germany
Boehringer Ingelheim

Terminated

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers

Healthy

Germany

3

Subscribe